Results 171 to 180 of about 5,890 (202)

Disposition of Antimony in Rhesus Monkeys Infected withLeishmania braziliensisand Treated with Meglumine Antimoniate

Journal of Toxicology and Environmental Health, Part A, 2011
Antimony (Sb) disposition and toxicity was evaluated in Leishmania braziliensis-infected monkeys (Macaca mulatta) treated with a 21-d course of low (LOW) or standard (STD) meglumine antimoniate (MA) dosage regimens (5 or 20 mg Sb(V)/kg body weight/d im).
Karen, Friedrich, Flávia A, Vieira, Renato, Porrozzi, Renato S, Marchevsky, Norbert, Miekeley, Gabriel, Grimaldi, Francisco J R, Paumgartten   +6 more
openaire   +2 more sources

The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis

Annals of Tropical Medicine & Parasitology, 2003
It would be very useful to have a more effective and more rapid method available for the treatment of cutaneous leishmaniasis (CL). The main aim of the present, Iranian study, was to see if the combination of cryotherapy and intralesional injections with meglumine antimoniate (C + MA) would be more effective than the injections given alone (MA) or the ...
A, Asilian, A, Sadeghinia, G, Faghihi, A, Momeni, A, Amini Harandi   +4 more
openaire   +2 more sources

Chemotherapy of Mediterranean Visceral Leishmaniasis with Meglumine Antimoniate

1989
Over the last years many trials have been performed to obtain adequate new drug delivery systems which could carry drugs directly to macrophages. In such systems, liposome [1] or cell ghosts [2] could carry smaller amounts of conventional drugs with a high efficacy and obviously lower toxicity. However, they are as yet only experimental systems.
Luis Tavares, Celia Carvalho, Eduardo Monteiro   +2 more
openaire   +1 more source

Localized leishmaniasis treated with intralesional meglumine antimoniate

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020
Uriel, Villela-Segura, Héctor, Proy-Trujillo, Ixtabay, Ilizaliturri-Flores, Victor Javier, Leal-Ascencio, Nixma, Eljure-López   +4 more
openaire   +2 more sources

Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.

Acta dermatovenerologica Croatica : ADC, 2008
Treatment of cutaneous leishmaniasis is often difficult. Even though most cutaneous lesions will heal spontaneously, their duration cannot be predicted in an individual case. In general, only large, multiple or diffuse lesions of the face, head and neck need to be considered for therapeutic intervention.
Abrar, Munir, Shahbaz A, Janjua, Ijaz, Hussain   +2 more
openaire   +1 more source

Systemic meglumine antimoniate‐induced severe dilated cardiomyopathy

Dermatologic Therapy, 2022
Nesrine Ben Salah, Amina Aounallah, Linda Manaa, Maha Lahouel, Haifa Mkhinini, Colandane Belajouza, Mohamed Denguezli   +6 more
openaire   +2 more sources

Meglumine antimoniate

Reactions Weekly, 1996
openaire   +1 more source

Meglumine antimoniate

Reactions Weekly, 2000
openaire   +1 more source

Meglumine antimoniate

Reactions Weekly, 2017
openaire   +1 more source

Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate

British Journal of Dermatology, 1998
Aste N, Pau M, FERRELI, CATERINA, Biggio P.   +3 more
openaire   +3 more sources